Clinical test could be undertaken after researchers at the University of Massachusetts Medical School have reported early success using a dual therapy targeting one of the most deadly forms of brain cancer.

As they report in the September issue of Cancer Research, a journal of the American Association for Cancer Research, the UMass researchers have been using the combination of two pharmaceuticals, temozolomide and a drug known as a notch inhibitor, against glioblastoma multiforme. Read full story here.